Copeland Capital Management LLC Has $39.87 Million Stock Position in Cabot Corporation $CBT

Copeland Capital Management LLC reduced its holdings in shares of Cabot Corporation (NYSE:CBT) by 29.1% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 524,278 shares of the specialty chemicals company’s stock after selling 215,412 shares during the quarter. Copeland Capital Management LLC owned 0.99% of Cabot worth $39,872,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. GAMMA Investing LLC increased its holdings in Cabot by 12.3% in the 2nd quarter. GAMMA Investing LLC now owns 1,909 shares of the specialty chemicals company’s stock worth $143,000 after purchasing an additional 209 shares in the last quarter. Penserra Capital Management LLC grew its holdings in shares of Cabot by 65.7% during the second quarter. Penserra Capital Management LLC now owns 6,609 shares of the specialty chemicals company’s stock worth $495,000 after purchasing an additional 2,620 shares during the last quarter. First Citizens Bank & Trust Co. increased its stake in shares of Cabot by 144.4% in the second quarter. First Citizens Bank & Trust Co. now owns 14,352 shares of the specialty chemicals company’s stock valued at $1,076,000 after buying an additional 8,479 shares during the period. Park Avenue Securities LLC acquired a new position in shares of Cabot in the second quarter valued at approximately $312,000. Finally, American Century Companies Inc. raised its holdings in Cabot by 11.1% in the 2nd quarter. American Century Companies Inc. now owns 1,664,728 shares of the specialty chemicals company’s stock valued at $124,855,000 after buying an additional 166,460 shares during the last quarter. Institutional investors own 93.18% of the company’s stock.

Analyst Upgrades and Downgrades

CBT has been the subject of several recent research reports. JPMorgan Chase & Co. decreased their price target on shares of Cabot from $75.00 to $54.00 and set an “underweight” rating for the company in a research report on Friday, November 28th. UBS Group decreased their price objective on Cabot from $82.00 to $65.00 and set a “neutral” rating for the company in a report on Wednesday, November 5th. Mizuho lifted their target price on Cabot from $72.00 to $80.00 and gave the stock an “outperform” rating in a report on Thursday, December 18th. Zacks Research cut Cabot from a “hold” rating to a “strong sell” rating in a research note on Friday, November 7th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Cabot in a research note on Monday, December 22nd. One equities research analyst has rated the stock with a Buy rating, two have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Reduce” and a consensus price target of $66.33.

Cabot Stock Performance

CBT stock opened at $66.13 on Tuesday. The firm has a market cap of $3.50 billion, a PE ratio of 11.00, a price-to-earnings-growth ratio of 3.48 and a beta of 0.90. The company has a current ratio of 1.61, a quick ratio of 1.08 and a debt-to-equity ratio of 0.50. The stock has a 50-day moving average price of $65.08 and a 200-day moving average price of $72.57. Cabot Corporation has a 1-year low of $58.33 and a 1-year high of $92.89.

Cabot (NYSE:CBT) last released its earnings results on Monday, November 3rd. The specialty chemicals company reported $1.70 EPS for the quarter, missing the consensus estimate of $1.72 by ($0.02). The business had revenue of $899.00 million for the quarter, compared to analyst estimates of $967.02 million. Cabot had a return on equity of 24.55% and a net margin of 8.91%.The company’s revenue for the quarter was down 10.2% on a year-over-year basis. During the same period in the prior year, the business earned $1.80 EPS. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. As a group, equities research analysts expect that Cabot Corporation will post 7.57 earnings per share for the current year.

Cabot Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, December 12th. Investors of record on Friday, November 28th were given a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date was Friday, November 28th. Cabot’s payout ratio is presently 29.95%.

Cabot Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.